Showing 21 - 40 results of 60 for search '"Radiopharmaceutical"', query time: 0.06s Refine Results
  1. 21

    Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms by Joelle El-Amm, Ashley Freeman, Nihar Patel, Jeanny B. Aragon-Ching

    Published 2013-01-01
    “…While several radiopharmaceuticals were approved for pain palliation in mCRPC including strontium and samarium, alpharadin is the first radiopharmaceutical to show significant overall survival benefit. …”
    Get full text
    Article
  2. 22

    Folate Receptor–Targeted Single-Photon Emission Computed Tomography/Computed Tomography to Detect Activated Macrophages in Atherosclerosis: Can It Distinguish Vulnerable from Stabl... by Leah C.J. Winkel, Harald C. Groen, Bibi S. van Thiel, Cristina Müller, Antonius F.W. van der Steen, Jolanda J. Wentzel, Marion de Jong, Kim Van der Heiden

    Published 2014-01-01
    “…We investigated the feasibility of a folate-based radiopharmaceutical ( 111 In-EC0800) with high-resolution animal single-photon emission computed tomography/computed tomography (SPECT/CT) to differentiate between stable and vulnerable atherosclerotic plaques in apolipoprotein E 7 mice in which we can induce plaques with the characteristics of stable and vulnerable plaques by placing a flow-modifying cast around the common carotid artery. …”
    Get full text
    Article
  3. 23
  4. 24

    Comparative Experiment on the Preparation of 99Mo/99mTc via Electron and Proton Irradiation of 100Mo by Desheng CHEN, Qinggang HUANG, Shiwei CAO, Zhi QIN

    Published 2025-02-01
    “…99mTc derived from 99Mo,stands as the preeminent radiopharmaceutical employed extensively in medical diagnostics worldwide. …”
    Get full text
    Article
  5. 25

    Quality of computed tomography image versus dose in hybrid studies: preliminary results in phantom by Adlin López Díaz, Armando del Pozo Almaguer, Adalberto Machado Tejeda, Karla Batista Ramó, Carlos F Calderón Marín, Leonel Torres Aroche

    Published 2022-03-01
    “…<p><strong>Background:</strong> hybrid studies produce a total radiation dose that is the result of the dose imparted by the radiopharmaceutical and that emitted by the computed tomography, therefore optimization is essential.…”
    Get full text
    Article
  6. 26

    Emerging Role of PET in the Diagnosis and Staging of Lung Cancer by Geoffery Coates, Stephen J Skehan

    Published 1999-01-01
    “…Malignant tumours demonstrate increased uptake of FDG, a positron-emitting radiopharmaceutical. This increased FDG uptake in tumours can be seen using PET. …”
    Get full text
    Article
  7. 27
  8. 28

    The Role of Dynamic Renal Scintigraphy in Detecting Vesicoureteral Reflux Diagnosed by Voiding Cystourethrogram by İlhan Çiftci, Gonca Kara Gedik, Farise Yılmaz, Fatma Özcan Sıkı, Hasan Önner, Mehmet Sarıkaya

    Published 2023-10-01
    “…Tc-99m MAG-3 was used in infants and Tc-99m DTPA radiopharmaceutical in children over one year old. According to VCUG findings, VUR grades were grouped as grade I-II-III low-grade VUR and IV-V high-grade VUR. …”
    Get full text
    Article
  9. 29

    Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma by Julian L. Goggi, Boominathan Ramasamy, Yun Xuan Tan, Siddesh V. Hartimath, Jun Rong Tang, Peter Cheng, Rasha Msallam, Ann-Marie Chacko, You Yi Hwang, Edward G. Robins

    Published 2021-01-01
    “…FACS indicated significant changes in the immune environment including a decrease in immune suppressive CD4+ T regulatory cells and increases in tumour-associated GZB+ NK+ cells, which correlated well with tumour radiopharmaceutical uptake. While the immune response to ICI therapies differs in HCC compared to many other cancers, [18F]AlF-mNOTA-GZP retention is able to stratify response to ICI therapy associated with tumour infiltrating GZB+ NK+ cells in this complex tumour microenvironment.…”
    Get full text
    Article
  10. 30

    Investigating the significance of SPECT/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review by Tahani O. Alkahtani

    Published 2025-01-01
    “…This imaging technique determines the radiopharmaceutical distribution and internal dosimetry in patients who receive TRT. …”
    Get full text
    Article
  11. 31
  12. 32

    Can Radiomics of Dynamic PET Imaging with 11C-methionine Predict EGFR Amplification Status in Glioblastoma? by Gleb DANILOV, Andrey POSTNOV, Diana KALAEVA, Nina VIKHROVA, Tatyana KOBYAKOVA

    Published 2024-11-01
    “…Three datasets were used to predict EGFR amplification status via machine learning: 1) Radiomic features calculated as time series for each image biomarker; 2) Dynamic tumor-to-normal brain ratio (T/N) of radiopharmaceutical uptake - time series of T/N peak for 26 frames; 3) Static T/N - peak, max, and average T/N for static images. …”
    Get full text
    Article
  13. 33

    Preliminary Assessment of Reference Region Quantification and Reduced Scanning Times for [18F]SynVesT-1 PET in Parkinson’s Disease by Kelly Smart, Carme Uribe, Kimberly L. Desmond, Sarah L. Martin, Neil Vasdev, Antonio P. Strafella

    Published 2023-01-01
    “…While [18F]SynVesT-1 has been proven to be a powerful radiopharmaceutical for PET imaging of neurodegenerative disorders such as Parkinson’s disease (PD), its currently validated acquisition and quantification protocols are invasive and technically challenging in these populations due to the arterial sampling and relatively long scanning times. …”
    Get full text
    Article
  14. 34

    Radiocobalt-Labeling of a Polypyridylamine Chelate Conjugated to GE11 for EGFR-Targeted Theranostics by Lorraine Gaenaelle Gé, Mathias Bogetoft Danielsen, Aaraby Yoheswaran Nielsen, Mathias Lander Skavenborg, Niels Langkjær, Helge Thisgaard, Christine J. McKenzie

    Published 2025-01-01
    “…In conclusion, [<sup>57</sup>Co]Co-TZTPEN-GE11 shows poor pharmacokinetics in a mouse model and is, therefore, not deemed suitable as a targeting radiopharmaceutical for EGFR.…”
    Get full text
    Article
  15. 35

    Detection Performance of 99mTc in Albira SI Small-Animal SPECT-CT by Jie TANG, Dong XU, Qianyue HU, Bo ZHANG, Wei LI, Lizhen WANG, Huixin YU, Fukuan ZHAO

    Published 2025-02-01
    “…Small-animal single-photon emission computed tomography-X-ray computed tomography (SPECT-CT) is an advanced imaging tool for preclinical research of single-photon radiopharmaceuticals. Its detection performance is the foundation of image quality and the reliability of experimental data. …”
    Get full text
    Article
  16. 36

    Sorption Characteristics and Chromatographic Separation of 90Y3+ from 90Sr2+ from Aqueous Media by Chelex-100 (Anion Ion Exchange) Packed Column by Mohammad S. El-Shahawi, Hassan Alwael, Abdulaziz A. Alsibaai, Abdelgany Hamza, Faisal K. Algethami, Fatmah M. Alshareef, Sanaa H. El-Khouly, Neven Eweda

    Published 2024-01-01
    “…There is growing demand for separation of 90Y carrier free from 90Sr coexisting to produce high purity 90Y essential for radiopharmaceutical uses. Thus, in this context the sorption profiles of Y3+ and Sr2+ from aqueous solutions containing diethylenetriaminepenta acetic acid (DTPA), ethylenediaminetetra-acetic acid (EDTA), acetic acid, citric acid, or NaCl onto Chelex-100 (anion ion exchange) solid sorbent were critically studied for developing an efficient and low-cost methodology for selective separation of Y3+ from Sr2+ ions (1.0 × 10−5 M). …”
    Get full text
    Article
  17. 37

    Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer Chromatography by Marc Pretze, Jan Wendrich, Holger Hartmann, Robert Freudenberg, Ralph A. Bundschuh, Jörg Kotzerke, Enrico Michler

    Published 2024-12-01
    “…A difference was observed when measuring TLC with the AR-2000 in different modes; (4) <b>Conclusions</b>: The MiniScanPRO+ is fast, does not require additional equipment and can also measure the gamma spectrum, which may be important for some radiopharmaceutical production sites and regulatory authorities. …”
    Get full text
    Article
  18. 38

    PET imaging of 52Mn labeled DOTATATE and DOTAJR11 by James M. Omweri, Hailey A. Houson, Shannon E. Lynch, Volkan Tekin, Anna G. Sorace, Suzanne E. Lapi

    Published 2025-01-01
    “…Abstract Manganese-52 is gaining interest as an isotope for PET imaging due to its desirable decay and chemical properties for radiopharmaceutical development. Somatostatin receptor 2 (SSTR2) is significantly overexpressed by neuroendocrine tumors (NETs) and is an important target for nuclear imaging and therapy. …”
    Get full text
    Article
  19. 39
  20. 40